CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancer
M. Rodrigo-Faus, A. Vincelle-Nieto, N. Vidal, J. Puente, M. Saiz-Pardo, A. Lopez-Garcia, M. Mendiburu-Elicabe, N. Palao, C. Baquero, A. M. Cuesta, H.-Q. Qu, H. Hakonarson, M. Musteanu, A. Reyes-Palomares, A. Porras, , A. Gutierrez-Uzquiza
This study identifies PRMT7 as a novel driver of metastasis in prostate cancer through CRISPR/Cas9 screens and validates its role in promoting cell motility and tumor dissemination.
bioRxiv · Jul 20, 2023 · PreprintCancer Biology